Abelev Gi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology.
According to data from OpenAlex, Abelev Gi has authored 34 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Abelev Gi's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Birth, Development, and Health (3 papers) and Immunotherapy and Immune Responses (3 papers). Abelev Gi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Birth, Development, and Health (3 papers) and Immunotherapy and Immune Responses (3 papers). Abelev Gi collaborates with scholars based in Russia. Abelev Gi's co-authors include Anatoli S. Gleiberman and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Abelev Gi
27 papers
receiving
392 citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of Abelev Gi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abelev Gi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abelev Gi more than expected).
This network shows the impact of papers produced by Abelev Gi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abelev Gi. The network helps show where Abelev Gi may publish in the future.
Co-authorship network of co-authors of Abelev Gi
This figure shows the co-authorship network connecting the top 25 collaborators of Abelev Gi.
A scholar is included among the top collaborators of Abelev Gi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Abelev Gi. Abelev Gi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Gi, Abelev, et al.. (2007). [The purification of the protein alternative to alfa-fetoprotein].. PubMed. 41–5.
2.
Gleiberman, Anatoli S., et al.. (1989). Synthesis of alpha-fetoprotein in hepatocytes is co-ordinately regulated with cell-cell and cell-matrix interactions.. PubMed. 6(2). 95–107.13 indexed citations
Gi, Abelev. (1982). [Immunodiagnosis of tumors].. PubMed. 61–5.1 indexed citations
5.
Gi, Abelev, et al.. (1981). [Independence of alpha-fetoprotein expression from production of adult rat serum proteins in hepatoma McA-RH7777].. PubMed. 92(9). 333–5.1 indexed citations
6.
Gi, Abelev, et al.. (1979). [Two-layer rocket-electrophoresis on cellulose-acetate membranes].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 88(9). 369–71.
7.
Gi, Abelev, et al.. (1977). [Synthesis of alpha-fetoprotein and albumin human embryo hepatocytes].. PubMed. 83(6). 711–3.2 indexed citations
Gi, Abelev, et al.. (1971). [Evaluation of the use of highly sensitive methods of determining alpha-fetoprotein for the diagnosis of hepatocellular cancer and teratoblastoma].. PubMed. 71(4). 75–81.12 indexed citations
10.
Gi, Abelev, et al.. (1968). [In vitro synthesis of serum embryonic antigens by the liver].. PubMed. 13(4). 378–83.4 indexed citations
11.
Gi, Abelev, et al.. (1968). [Distribution of the tumor-specific antigen of virus-induced mouse leukemia (Rauscher) after electrophoresis in agar gel].. PubMed. 33(3). 509–16.2 indexed citations
Gi, Abelev, et al.. (1963). Antigenic structure of mouse hepatomas. II. Preparation of monospecific antibodies to the organospecific liver antigens.. PubMed. 10. 121–6.1 indexed citations
14.
Gi, Abelev, et al.. (1962). [The antigenic structure of mouse hepatomas. I. Organ-specific antigens of the liver and immuno-electrophoretic study of their occurrence in hepatomas].. PubMed. 9. 123–30.2 indexed citations
15.
Gi, Abelev, et al.. (1961). [Limits of sensitivity of the agar precipitation method].. PubMed. 52. 107–11.5 indexed citations
16.
Gi, Abelev, et al.. (1960). [Isolation of specific antigens of transplanted mouse hepatoma by means of an immuno-filtration method].. PubMed. 6(6). 62–72.1 indexed citations
17.
Gi, Abelev, et al.. (1960). [Isolation of precipitating antibodies to specific antigens of the liver and mouse hepatoma].. PubMed. 6(6). 57–62.1 indexed citations
18.
Gi, Abelev. (1960). [A modification of the method of precipitation in agar for comparison of two systems of antigen-antiserum].. PubMed. 49. 118–20.4 indexed citations
19.
Gi, Abelev, et al.. (1959). Antibody formation in primary rat sarcomas induced with carcinogens.. PubMed. 6. 353–60.3 indexed citations
20.
Gi, Abelev, et al.. (1955). [Localization of specific antigens in tumor tissue].. PubMed. 100(2). 331–4.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.